StockData
Quest Diagnostics Inc logo

Quest Diagnostics Inc (DGX) stock

DGXNYSEServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 23, 2026Score 12/308% above fair value
$259.69+3.34 (+1.30%)

Close on Nov 18, 2026Market cap $28.57BP/E 25.9Yield –

Quest Diagnostics operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Quest Diagnostics's operating income for the twelve months ending Sep 30, 2026 was $1.72B, up 12.5% year over year. For fiscal 2025 it was $1.56B, up 15.6% from the year before. Over ten years it grew 1.1% a year on average. The highest annual figure on record is $2.38B in fiscal 2021.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.56B+15.6%
FY2024Dec 31, 2024$1.35B+6.7%
FY2023Dec 31, 2023$1.26B-11.6%
FY2022Dec 31, 2022$1.43B-40.0%
FY2021Dec 31, 2021$2.38B+20.8%
FY2020Dec 31, 2020$1.97B+60.1%
FY2019Dec 31, 2019$1.23B+11.8%
FY2018Dec 31, 2018$1.10B-5.5%
FY2017Dec 31, 2017$1.17B-8.8%
FY2016Dec 31, 2016$1.28B-8.7%
FY2015Dec 31, 2015$1.40B+42.3%
FY2014Dec 31, 2014$983.00M-33.4%
FY2013Dec 31, 2013$1.48B+22.8%
FY2012Dec 31, 2012$1.20B+21.7%
FY2011Dec 31, 2011$987.00M-23.1%
FY2010Dec 31, 2010$1.28B-5.6%
FY2009Dec 31, 2009$1.36B+11.2%
FY2008Dec 31, 2008$1.22B+12.0%
FY2007Dec 31, 2007$1.09B–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$479.00M+24.1%
Q2 FY2026Jun 30, 2026$459.00M+4.8%
Q1 FY2026Mar 31, 2026$399.00M+15.3%
Q4 FY2025Dec 31, 2025$386.00M+6.9%
Q3 FY2025Sep 30, 2025$386.00M+17.0%
Q2 FY2025Jun 30, 2025$438.00M+23.4%
Q1 FY2025Mar 31, 2025$346.00M+15.3%
Q4 FY2024Dec 31, 2024$361.00M+35.2%
Q3 FY2024Sep 30, 2024$330.00M-3.5%
Q2 FY2024Jun 30, 2024$355.00M+2.0%
Q1 FY2024Mar 31, 2024$300.00M-1.6%
Q4 FY2023Dec 31, 2023$267.00M+97.8%
Q3 FY2023Sep 30, 2023$342.00M-12.8%
Q2 FY2023Jun 30, 2023$348.00M-10.3%
Q1 FY2023Mar 31, 2023$305.00M-40.5%
Q4 FY2022Dec 31, 2022$135.00M-74.8%
Q3 FY2022Sep 30, 2022$392.00M-39.9%
Q2 FY2022Jun 30, 2022$388.00M-27.2%
Q1 FY2022Mar 31, 2022$513.00M-22.3%
Q4 FY2021Dec 31, 2021$536.00M-32.6%
Q3 FY2021Sep 30, 2021$652.00M-9.2%
Q2 FY2021Jun 30, 2021$533.00M+88.3%
Q1 FY2021Mar 31, 2021$660.00M+277.1%
Q4 FY2020Dec 31, 2020$795.00M+119.0%
Q3 FY2020Sep 30, 2020$718.00M+129.4%
Q2 FY2020Jun 30, 2020$283.00M-7.8%
Q1 FY2020Mar 31, 2020$175.00M-29.4%
Q4 FY2019Dec 31, 2019$363.00M+65.0%
Q3 FY2019Sep 30, 2019$313.00M+3.0%
Q2 FY2019Jun 30, 2019$307.00M+0.7%
Q1 FY2019Mar 31, 2019$248.00M-8.8%
Q4 FY2018Dec 31, 2018$220.00M-18.2%
Q3 FY2018Sep 30, 2018$304.00M+2.0%
Q2 FY2018Jun 30, 2018$305.00M-4.4%
Q1 FY2018Mar 31, 2018$272.00M-2.5%
Q4 FY2017Dec 31, 2017$269.00M-2.5%
Q3 FY2017Sep 30, 2017$298.00M–
Q2 FY2017Jun 30, 2017$319.00M–
Q1 FY2017Mar 31, 2017$279.00M–
Q4 FY2016Dec 31, 2016$276.00M–

More Quest Diagnostics figures

See a number that looks wrong?